Koronis Pharma, Inc. — Form D

Koronis Pharma, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2012-01-09. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2012-01-09
• Form: D
• Accession: 0001539008-12-000001
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $2.0M
• Amount sold: $1.0M
• Remaining: $1.0M
• Investors: 1
• Date of first sale: 2011-12-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-171443

Issuer

• Name: Koronis Pharma, Inc.
• CIK: 0001539008
• Entity type: Corporation
• Jurisdiction: WASHINGTON
• Incorporated: 2011
• Address: 800 FIFTH AVENUE, SEATTLE, WA, 98104
• Phone: 206-682-1181

Officers, directors & promoters (7)

Other filings by this issuer (1)

More

• CIK 1539008 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search